Anne M Grool1, Mirjam I Geerlings, Sigurdur Sigurdsson, Gudny Eiriksdottir, Palmi V Jonsson, Melissa E Garcia, Kristin Siggeirsdottir, Tamara B Harris, Thordur Sigmundsson, Vilmundur Gudnason, Lenore J Launer. 1. From the Julius Center for Health Sciences and Primary Care (A.M.G., M.I.G.) and Department of Radiology (A.M.G.), University Medical Center Utrecht, the Netherlands; National Institute on Aging (M.I.G., M.E.G., T.B.H., L.J.L.), Laboratory for Epidemiology, Demography, and Biometry, Bethesda, MD; Icelandic Heart Association (S.S., G.E., P.V.J., K.S., V.G.), Kopavogur; Janus Rehabilitation (K.S.), Vorduskola v/Egilsgotu, Reykjavik; Landspitali University Hospital (T.S.), Reykjavik; and University of Iceland (V.G.), Reykjavik, Iceland.
Abstract
OBJECTIVE: We aimed to investigate the relation between apathy symptoms and structural brain changes on MRI, including white matter lesions (WMLs) and atrophy, in a large cohort of older persons. METHODS: Cross-sectional analyses are based on 4,354 persons without dementia (aged 76 ± 5 years) participating in the population-based Age, Gene/Environment Susceptibility-Reykjavik Study. Apathy symptoms were assessed with 3 items from the 15-item Geriatric Depression Scale. Brain volumes and total WML volume were estimated on 1.5-tesla MRI using an automated segmentation program; regional WML load was calculated using a semiquantitative scale. Regression analyses were adjusted for age, sex, education, intracranial volume, vascular risk factors, physical activity, brain infarcts, depressive symptoms, antidepressants, and cognitive status. RESULTS: Compared to those with <2 apathy symptoms, participants with ≥ 2 apathy symptoms (49% of the cohort) had significantly smaller gray matter volumes (mean adjusted difference -3.6 mL, 95% confidence interval [CI] -6.2 to -1.0), particularly in the frontal and temporal lobes; smaller white matter volumes (mean adjusted difference -1.9 mL, 95% CI -3.6 to -0.3), mainly in the parietal lobe; and smaller thalamus volumes. They were also more likely to have WMLs in the frontal lobe (adjusted odds ratio = 1.08, 95% CI 0.9-1.3). Excluding participants with a depression diagnosis did not change the associations. CONCLUSIONS: In this older population without dementia, apathy symptoms are associated with a more diffuse loss of both gray and white matter volumes, independent of depression.
OBJECTIVE: We aimed to investigate the relation between apathy symptoms and structural brain changes on MRI, including white matter lesions (WMLs) and atrophy, in a large cohort of older persons. METHODS: Cross-sectional analyses are based on 4,354 persons without dementia (aged 76 ± 5 years) participating in the population-based Age, Gene/Environment Susceptibility-Reykjavik Study. Apathy symptoms were assessed with 3 items from the 15-item Geriatric Depression Scale. Brain volumes and total WML volume were estimated on 1.5-tesla MRI using an automated segmentation program; regional WML load was calculated using a semiquantitative scale. Regression analyses were adjusted for age, sex, education, intracranial volume, vascular risk factors, physical activity, brain infarcts, depressive symptoms, antidepressants, and cognitive status. RESULTS: Compared to those with <2 apathy symptoms, participants with ≥ 2 apathy symptoms (49% of the cohort) had significantly smaller gray matter volumes (mean adjusted difference -3.6 mL, 95% confidence interval [CI] -6.2 to -1.0), particularly in the frontal and temporal lobes; smaller white matter volumes (mean adjusted difference -1.9 mL, 95% CI -3.6 to -0.3), mainly in the parietal lobe; and smaller thalamus volumes. They were also more likely to have WMLs in the frontal lobe (adjusted odds ratio = 1.08, 95% CI 0.9-1.3). Excluding participants with a depression diagnosis did not change the associations. CONCLUSIONS: In this older population without dementia, apathy symptoms are associated with a more diffuse loss of both gray and white matter volumes, independent of depression.
Authors: A M Grool; Y van der Graaf; W P Th M Mali; Th D Witkamp; K L Vincken; M I Geerlings Journal: Psychol Med Date: 2011-08-11 Impact factor: 7.723
Authors: George S Alexopoulos; Dimitris N Kiosses; Sibel Klimstra; Balkrishna Kalayam; Martha L Bruce Journal: Am J Geriatr Psychiatry Date: 2002 Jan-Feb Impact factor: 4.105
Authors: R D Nebes; I J Vora; C C Meltzer; M B Fukui; R L Williams; M I Kamboh; J Saxton; P R Houck; S T DeKosky; C F Reynolds Journal: Am J Psychiatry Date: 2001-06 Impact factor: 18.112
Authors: K Ranga Rama Krishnan; Warren D Taylor; Douglas R McQuoid; James R MacFall; Martha E Payne; James M Provenzale; David C Steffens Journal: Biol Psychiatry Date: 2004-02-15 Impact factor: 13.382
Authors: Thomas T van Sloten; Gary F Mitchell; Sigurdur Sigurdsson; Mark A van Buchem; Palmi V Jonsson; Melissa E Garcia; Tamara B Harris; Ronald M A Henry; Andrew S Levey; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer Journal: J Psychiatry Neurosci Date: 2016-04 Impact factor: 6.186
Authors: Matthew J Hollocks; Andrew J Lawrence; Rebecca L Brookes; Thomas R Barrick; Robin G Morris; Masud Husain; Hugh S Markus Journal: Brain Date: 2015-10-21 Impact factor: 13.501
Authors: Rianne M van der Linde; Tom Dening; Blossom C M Stephan; A Matthew Prina; Elizabeth Evans; Carol Brayne Journal: Br J Psychiatry Date: 2016-08-04 Impact factor: 9.319
Authors: Jan Willem van Dalen; Lennard L Van Wanrooij; Eric P Moll van Charante; Edo Richard; Willem A van Gool Journal: Neurology Date: 2017-12-01 Impact factor: 9.910